| 1401 |
|
Safety and efficacy of CpG-containing oligodeoxynucleotides as immunological adjuvants in rabbits/
|
Ioannou, X. P
|
Butterworths
|
2003
|
|
|
|
| 1402 |
|
Safety and immunogenicity of an acellular pertussis diphtheria tetanus vaccine given as a single injection with Haemophilus influenzae b conjugate vaccine
|
Halperin, S. A
|
Butterworths
|
1997
|
|
|
|
| 1403 |
|
Safety and immunogenicity of an oral, inactivated enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine in Bangladeshi children 18-36 months of age/
|
Qadri, F
|
Butterworths
|
2003
|
|
|
|
| 1404 |
|
Safety and immunogenicity of an oral inactivated enterotoxigenic Escherichia coli vaccine
|
Jertborn, M
|
Butterworths
|
1998
|
|
|
|
| 1405 |
|
Safety and immunogenicity of a novel mammalian cell-derived recombinant hepatitis B vaccine containing Pre-S1 and Pre-S2 antigens in children
|
Raz, R
|
Butterworths
|
1997
|
|
|
|
| 1406 |
|
Safety and immunogenicity of a peptide containing the cross-neutralization epitope of HPV16 L2 administered nasally in healthy volunteers/
|
Kawana, K
|
Butterworths
|
2003
|
|
|
|
| 1407 |
|
Safety and immunogenicity of a Pseudomonas aeruginosa outer membrane protein I vaccine in human volunteers
|
Von Specht, B.-U
|
Butterworths
|
1996
|
|
|
|
| 1408 |
|
Safety and immunogenicity of a recombinant hepatitis B vaccine administered to infants at 2, 4 and 6 months of age
|
Greenberg, D. P
|
Butterworths
|
1996
|
|
|
|
| 1409 |
|
Safety and immunogenicity of a respiratory syncytial virus subunit vaccine (PFP-2) in ambulatory adults over age 60
|
Falsey, A. R
|
Butterworths
|
1996
|
|
|
|
| 1410 |
|
Safety and immunogenicity of a respiratory syncytial virus subunit vaccine (PFP-2) in the institutionalized elderly
|
Falsey, A. R
|
Butterworths
|
1997
|
|
|
|
| 1411 |
|
Safety and immunogenicity of a tetravalent group B streptococcal polysaccharide vaccine in healthy adults
|
Kotloff, K. L
|
Butterworths
|
1996
|
|
|
|
| 1412 |
|
Safety and immunogenicity of a three-component blood-stage malaria vaccine (MSP1, MSP2, RESA) against Plasmodium falciparum in Papua New Guinean children/
|
Genton, B
|
Butterworths
|
2003
|
|
|
|
| 1413 |
|
Safety and immunogenicity of live, attenuated human rotavirus vaccine 89-12
|
Bernstein, D. I
|
Butterworths
|
1998
|
|
|
|
| 1414 |
|
Safety and immunogenicity of live attenuated quadrivalent human-bovine (UK) reassortant rotavirus vaccine administered with childhood vaccines to infants/
|
Clements-Mann, Mary Lou
|
Butterworths
|
2001
|
|
|
|
| 1415 |
|
Safety and immunogenicity of Lyssavac Berna human diploid cell rabies vaccine in healthy adults
|
Briggs, D. J
|
Butterworths
|
1996
|
|
|
|
| 1416 |
|
Safety and immunogenicity of REMUNE^T^m in HIV-infected Thai subjects
|
Limsuwan, A
|
Butterworths
|
1998
|
|
|
|
| 1417 |
|
Safety and immunogenicity of respiratory syncytial virus purified fusion protein-2 vaccine in pregnant women/
|
Munoz, F. M
|
Butterworths
|
2003
|
|
|
|
| 1418 |
|
Safety and immunogenicity of varying dosages of trivalent inactivated influenza vaccine administered by needle-free jet injectors/
|
Jackson, Lisa A
|
Butterworths
|
2001
|
|
|
|
| 1419 |
|
Safety and protective efficacy of porcine reproductive and respiratory syndrome recombinant virus vaccines in young pigs/
|
Verheije, M. H
|
Butterworths
|
2003
|
|
|
|
| 1420 |
|
Safety, efficacy, and immunogenicity of a recombinant Osp subunit canineLyme disease vaccine
|
Ma, J
|
Butterworths
|
1996
|
|
|
|